Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis.
Type 1 diabetes with periodontitis shows elevated TNF-α expression. Tumor necrosis factor (TNF)-α stimulates the expression of receptor activator of nuclear factor-κB ligand (RANKL) and sclerostin. The objective of this study was to determine the effect of TNF-α expression of osteocytic RANKL and sc...
Main Authors: | Ji-Hye Kim, Ae Ri Kim, Yun Hui Choi, Sungil Jang, Gye-Hyeong Woo, Jeong-Heon Cha, Eun-Jung Bak, Yun-Jung Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5730195?pdf=render |
Similar Items
-
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
by: Asiri R Wijenayaka, et al.
Published: (2011-01-01) -
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
by: Marciana Laster, et al.
Published: (2023-09-01) -
Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
by: Yentl Huybrechts, et al.
Published: (2023-01-01) -
Lipopolysaccharides of Fusobacterium nucleatum and Porphyromonas gingivalis increase RANKL-expressing neutrophils in air pouches of mice
by: Ae Ri Kim, et al.
Published: (2021-01-01) -
Correction to: Lipopolysaccharides of Fusobacterium nucleatum and Porphyromonas gingivalis increase RANKL-expressing neutrophils in air pouches of mice
by: Ae Ri Kim, et al.
Published: (2021-08-01)